Clinical Trials Logo

Clinical Trial Summary

A Multi-center, Randomized, Double-blind, Placebo-controlled, Therapeutic Exploratory, Phase II Clinical Trial for the Efficacy Investigation and Safety Evaluation of DWP708 for Treating Rash Acneiform


Clinical Trial Description

All the patients had Grade ≥2 ERSEs according to the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI-CTCAE) v. 5.0 ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05378360
Study type Interventional
Source Daewoong Pharmaceutical Co. LTD.
Contact
Status Completed
Phase Phase 2
Start date May 2, 2022
Completion date December 28, 2023